Abstract
CART peptides are endogenous neurotransmitters that are involved in a variety of physiologic functions. Injection of CART 55-102 into the nucleus accumbens produces no effect, but when co-administered with cocaine, it reduces the locomotor and rewarding properties of cocaine. In a human study, subjects carrying a missense mutation of the CART gene exhibited increased anxiety and depression. Also, several animal studies support the idea that CART is involved in anxiety and depression, and they also suggest several possible mechanisms by which this may occur. Thus, there is interesting evidence that CART peptides play a role in anxiety and depression, and that CART peptides may be endogenous antidepressants.
Keywords: CART peptide, antidepressant, depression, forced swim test, anxiety, arousal, drug abuse, CART Peptides, Antidepressants, Psychostimulants, Endogenous, adrenocorticotropin hormone, hypothalamic-pituitary-somatotrophic (HPS) axis
Current Neuropharmacology
Title: CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
Volume: 9 Issue: 1
Author(s): M. O. Job, I. M. McNamara and M. J. Kuhar
Affiliation:
Keywords: CART peptide, antidepressant, depression, forced swim test, anxiety, arousal, drug abuse, CART Peptides, Antidepressants, Psychostimulants, Endogenous, adrenocorticotropin hormone, hypothalamic-pituitary-somatotrophic (HPS) axis
Abstract: CART peptides are endogenous neurotransmitters that are involved in a variety of physiologic functions. Injection of CART 55-102 into the nucleus accumbens produces no effect, but when co-administered with cocaine, it reduces the locomotor and rewarding properties of cocaine. In a human study, subjects carrying a missense mutation of the CART gene exhibited increased anxiety and depression. Also, several animal studies support the idea that CART is involved in anxiety and depression, and they also suggest several possible mechanisms by which this may occur. Thus, there is interesting evidence that CART peptides play a role in anxiety and depression, and that CART peptides may be endogenous antidepressants.
Export Options
About this article
Cite this article as:
O. Job M., M. McNamara I. and J. Kuhar M., CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017074
DOI https://dx.doi.org/10.2174/157015911795017074 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Combinatorial Chemistry & High Throughput Screening Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics
Current Drug Safety Plasma-Rich in Growth Factor and its Clinical Application
Current Stem Cell Research & Therapy Medicinal Chemistry and Pharmacology of A2B Adenosine Receptors
Current Topics in Medicinal Chemistry Aspects of the Stability and Bioavailability of Carbohydrates and Carbohydrate Derivatives
Mini-Reviews in Medicinal Chemistry Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Nanoscience & Nanotechnology-Asia Poor Prognostic Outcome in Cerebral Venous Sinus Thrombosis Associated with Dyskinesia and Elevated Platelet Volume
Current Neurovascular Research GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications
Current Topics in Medicinal Chemistry Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders
Current Pharmaceutical Biotechnology Mild Cognitive Impairment (MCI) - The Novel Trend of Targeting Alzheimers Disease in Its Early Stages - Methodological Considerations
Current Alzheimer Research Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research B Cell Depletion in Systemic Vasculitis
Current Immunology Reviews (Discontinued) The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy
Current Topics in Medicinal Chemistry The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease
Current Pharmaceutical Design Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
Current Pharmaceutical Design Pollen-Cross Allergenicity Mediated by Panallergens: A Clue to the Pathogenesis of Multiple Sensitizations
Inflammation & Allergy - Drug Targets (Discontinued) Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Proteochemometrics for the Prediction of Binding to the MHC Proteins
Letters in Drug Design & Discovery